Limited Offer
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Emerging Paradigms in Delivery Systems for Antitubercular Therapy
- 1st Edition - January 1, 2025
- Editors: Rajeev Sharma, Neeraj Mishra, Laxmikant Gautam, S.P. Vyas
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 2 4 0 3 5 - 5
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 2 4 0 3 4 - 8
Emerging Paradigms in Delivery Systems for Antitubercular Therapy provides an up-to-date and thorough overview of the state-of-the-art of concepts, design, and recent advances… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteEmerging Paradigms in Delivery Systems for Antitubercular Therapy provides an up-to-date and thorough overview of the state-of-the-art of concepts, design, and recent advances in nanomedicines and nanobiotechnology-based strategies for the treatment of tuberculosis. The book enables researchers to prepare a variety of nanotechnology-based strategies, investigate their properties, and discover their uses and applications in antitubercular therapy, focusing on advanced nanomaterials that are utilized for encapsulation of nucleic acid, mRNA, DNA, and tuberculosis vaccination.
This book covers all major topics that have shaped the development of nanomedicine and propelled it to its current place at the forefront of Nanotechnology based treatment innovation. It will be a welcomed resource for researchers and readers with more and more challenging therapy and biologicals with their possible modifications to be used for the effective therapy of tuberculosis.
- Focuses on advanced nanomaterials that are utilized for encapsulation of nucleic acid, mRNA, DNA, and tuberculosis vaccination
- Covers all major topics that have shaped the development of nanomedicine and propelled it to its current place at the forefront of nanotechnology based treatment innovation
- Provides assistance to researchers and readers with more and more challenging therapy and biologicals with their possible modifications to be used for effective therapies in tuberculosis
Researchers, specialists, and scientists in the field of pharmacology focusing on infectious, respiratory, and lung disease, Undergraduate and postgraduate students from various disciplines such as pharmacy, microbiology, immunology, pharmacology, biotechnology, and health sciences
1. Introduction: An Overview of Novel Approaches for the Treatment of Tuberculosis
2. Theragnostic Approaches for the Management of Tuberculosis
3. Role of Inorganic Nanoparticles for the Treatment of Tuberculosis
4. Role of Polymeric Nanoparticles for the Treatment of Tuberculosis
5. Role of Vesicular Carriers for the Treatment of Tuberculosis
6. Polymeric Micelles in Therapy of Tuberculosis
7. Herbal Approaches for the Treatment of Tuberculosis
8. Role of Gut-lung axis in Tuberculosis
9. Mucoadhesive Drug Delivery System(s) for the Treatment of Tuberculosis
10. Current Gene Therapy Approaches for the Treatment of Tuberculosis
11. Novel Targets and Drugs for the Treatment of Tuberculosis
12. Targeting Inflammation and Oxidative Stress for the Treatment of Tuberculosis
13. Potential Approaches for the Treatment of Drug-resistant Tuberculosis
14. Targeted Drug Delivery to the Macrophagic Cellular Tropics in Tuberculosis
15. Combination Antitubercular Therapy Using Nanomedicine to Treat and Eradicate Tuberculosis
16. Tuberculosis Vaccines: Advancements and Ongoing Clinical Trials
17. Future Prospects and Regulatory Aspects for the Management of Tuberculosis
2. Theragnostic Approaches for the Management of Tuberculosis
3. Role of Inorganic Nanoparticles for the Treatment of Tuberculosis
4. Role of Polymeric Nanoparticles for the Treatment of Tuberculosis
5. Role of Vesicular Carriers for the Treatment of Tuberculosis
6. Polymeric Micelles in Therapy of Tuberculosis
7. Herbal Approaches for the Treatment of Tuberculosis
8. Role of Gut-lung axis in Tuberculosis
9. Mucoadhesive Drug Delivery System(s) for the Treatment of Tuberculosis
10. Current Gene Therapy Approaches for the Treatment of Tuberculosis
11. Novel Targets and Drugs for the Treatment of Tuberculosis
12. Targeting Inflammation and Oxidative Stress for the Treatment of Tuberculosis
13. Potential Approaches for the Treatment of Drug-resistant Tuberculosis
14. Targeted Drug Delivery to the Macrophagic Cellular Tropics in Tuberculosis
15. Combination Antitubercular Therapy Using Nanomedicine to Treat and Eradicate Tuberculosis
16. Tuberculosis Vaccines: Advancements and Ongoing Clinical Trials
17. Future Prospects and Regulatory Aspects for the Management of Tuberculosis
- No. of pages: 400
- Language: English
- Edition: 1
- Published: January 1, 2025
- Imprint: Academic Press
- Paperback ISBN: 9780443240355
- eBook ISBN: 9780443240348
RS
Rajeev Sharma
Dr. Sharma earned his B. Pharm, M. Pharm and Ph.D. form Pharmaceutical Sciences, Dr. H. S. Gour Central University, Sagar, India. As Assistant Professor, he served in academia at Guru Ramdas Khalsa institute of Science and Technology Jabalpur (M.P.). He has the past experience as Junior research fellow-AICTE, ICMR-SRF and CSIR- research associate during his academic career and currently, working as an assistant manager in biologicals research and development division. He has edited 1 international book Nano Drug Delivery Strategies for the Treatment of Cancers and he published dozens of publications and book chapters. His current research interests are nanocarriers based targeted approach for the effective delivery of bioactives.
Affiliations and expertise
Assistant Professor, Amity institute of Pharmacy, Amity University, Gwalior, Madhya Pradesh, IndiaNM
Neeraj Mishra
Dr. Neeraj Mishra is a Professor and Head of the Department of Pharmaceutics at Amity Institute of Pharmacy, Gwalior, a position he has held since July 2019. With nearly two decades of teaching and research experience, Dr. Mishra has authored over 100 publications on novel drug delivery systems, focusing on nanocarriers and microparticles for treating breast and colon cancer, as well as neurodegenerative disorders. His work has garnered more than 3,500 citations, an h-index of 30, and a cumulative impact factor exceeding 300. He has written 10 books, 25 book chapters, and holds three international and two Indian patents. Dr. Mishra has received numerous accolades, including the "Distinguished Professor Award" (2019, 2021) and the "Outstanding Scientist Award" (2020). He has served as a guest editor for Bentham Sciences and is recognized in Stanford University's World Scientists Rankings for 2022 and 2024.
Affiliations and expertise
Professor and Head, Amity Institute of Pharmacy, Amity UniversityLG
Laxmikant Gautam
Laxmikant Gautam is a PhD Scholar in the Department of Pharmaceutical Sciences, Dr. Harisingh Gour University, Sagar, Madhya Pradesh, India.
Affiliations and expertise
PhD Scholar, Department of Pharmaceutical Sciences, Dr. Harisingh Gour University, Sagar, Madhya Pradesh, IndiaSV
S.P. Vyas
Professor S.P. Vyas works in the Department of Pharmacy, Dr. Harisingh Gour University, Sagar, Madhya Pradesh, India.
Affiliations and expertise
Professor, Department of Pharmacy, Dr. Harisingh Gour University, Sagar, Madhya Pradesh, India